CSF Proteomic Profiling of Progressive Supranuclear Palsy Phenotypes Highlights Lipid Remodeling, Heme Handling, and Neuroglial Injury
- 1Chair and Department of Biochemistry, Medical University of Warsaw, 02-097 Warsaw, Poland
- 2Department of Neurology, Medical University of Warsaw, 03-242 Warsaw, Poland
- 3Department of Infectious and Tropical Diseases and Hepatology, Medical University of Warsaw, 01-201 Warsaw, Poland
Abstract
Progressive supranuclear palsy (PSP) is a clinically heterogeneous four-repeat tauopathy, but the molecular links between redox biology, lipid remodeling, heme and iron handling, and neurodegeneration remain poorly defined. We performed untargeted LC-MS/MS proteomic profiling of cerebrospinal fluid from 12 patients with PSP-Richardson’s syndrome (PSP-RS), 12 with PSP-parkinsonism (PSP-P), and 12 controls. In the primary analysis, without adjustment for age and sex, 67 of the 2445 quantified protein groups showed significant differences in PSP-RS versus controls and 18 in PSP-P versus controls after FDR correction, with seven proteins shared between the two comparisons. No protein remained significant in the direct PSP-RS versus PSP-P comparison. In PSP-RS, functional enrichment highlighted lipid and lipoprotein remodeling, cholesterol transport, and accompanying complement-related pathways. No significant functional enrichment was detected in PSP-P using the experimental proteomic background. The prioritized protein panel revealed abundance changes associated with redox-related processes in PSP-RS. Increased CP and HPX were linked to iron and heme handling. Increased PON1, APOA1, APOM, and AFM were associated with lipid transport and antioxidant-related processes. Increased GFAP and SERPINA3 reflected astroglial and stress/injury responses, whereas decreased NPTX2 was consistent with synaptic and neuronal network involvement. AFM, GFAP, and SERPINA3 were also increased in PSP-P. Together, these protein-level and pathway-level findings suggest associations between lipid homeostasis, redox-related processes, and neuroglial injury in PSP. However, these findings do not establish molecular differences between PSP phenotypes, as no proteins remained significant in their direct comparison after FDR correction. In the age- and sex-adjusted sensitivity analysis, no protein groups remained significant after FDR correction in the disease-versus-control comparisons. These exploratory findings require confirmation in larger, age-matched cohorts with independent validation.
Related
- Circulating and vascular NAD+ metabolism remodeling in Tgαq*44 mice with progressive heart failure
- Persistence without turnover: the RhoG G12E mutant highlights the role of nucleotide cycling in RhoG signaling
- Cell DiffErential Expression by Pooling (CellDEEP) highlights issues in differential gene expression in scRNA-seq
- Distinct labeling of host and viral genomes highlights redistribution of nuclear proteins during HSV-1 infection
- The mode of action of neonicotinoids and related compounds on insect neuronal nicotinic acetylcholine receptors highlights complex intracellular calcium mechanisms
BibTeX
@article{ottoslusarczyk2026proteomic,
title = {{CSF Proteomic Profiling of Progressive Supranuclear Palsy Phenotypes Highlights Lipid Remodeling, Heme Handling, and Neuroglial Injury}},
author = {Dagmara Otto-Ślusarczyk and Piotr Alster and Alicja Wiercińska-Drapało and Marta Struga and Natalia Madetko-Alster},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272210235},
url = {https://www.mdpi.com/1422-0067/27/22/10235},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - CSF Proteomic Profiling of Progressive Supranuclear Palsy Phenotypes Highlights Lipid Remodeling, Heme Handling, and Neuroglial Injury
AU - Dagmara Otto-Ślusarczyk
AU - Piotr Alster
AU - Alicja Wiercińska-Drapało
AU - Marta Struga
AU - Natalia Madetko-Alster
PY - 2026
DA - 2026/11/15
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272210235
UR - https://www.mdpi.com/1422-0067/27/22/10235
AB - Progressive supranuclear palsy (PSP) is a clinically heterogeneous four-repeat tauopathy, but the molecular links between redox biology, lipid remodeling, heme and iron handling, and neurodegeneration remain poorly defined. We performed untargeted LC-MS/MS proteomic profiling of cerebrospinal fluid from 12 patients with PSP-Richardson’s syndrome (PSP-RS), 12 with PSP-parkinsonism (PSP-P), and 12 controls. In the primary analysis, without adjustment for age and sex, 67 of the 2445 quantified protein groups showed significant differences in PSP-RS versus controls and 18 in PSP-P versus controls after FDR correction, with seven proteins shared between the two comparisons. No protein remained significant in the direct PSP-RS versus PSP-P comparison. In PSP-RS, functional enrichment highlighted lipid and lipoprotein remodeling, cholesterol transport, and accompanying complement-related pathways. No significant functional enrichment was detected in PSP-P using the experimental proteomic background. The prioritized protein panel revealed abundance changes associated with redox-related processes in PSP-RS. Increased CP and HPX were linked to iron and heme handling. Increased PON1, APOA1, APOM, and AFM were associated with lipid transport and antioxidant-related processes. Increased GFAP and SERPINA3 reflected astroglial and stress/injury responses, whereas decreased NPTX2 was consistent with synaptic and neuronal network involvement. AFM, GFAP, and SERPINA3 were also increased in PSP-P. Together, these protein-level and pathway-level findings suggest associations between lipid homeostasis, redox-related processes, and neuroglial injury in PSP. However, these findings do not establish molecular differences between PSP phenotypes, as no proteins remained significant in their direct comparison after FDR correction. In the age- and sex-adjusted sensitivity analysis, no protein groups remained significant after FDR correction in the disease-versus-control comparisons. These exploratory findings require confirmation in larger, age-matched cohorts with independent validation.
SN - 1422-0067
ER -